VX-478 non-peptide HIV protease inhibitor data
Partner Burroughs Wellcome presented preclinical data showing an acceptable safety profile and synergism with AZT and ddI.
VRTX (Cambridge, Mass.) said the agent
Gathering data...
Partner Burroughs Wellcome presented preclinical data showing an acceptable safety profile and synergism with AZT and ddI.
VRTX (Cambridge, Mass.) said the agent